Profile
Fardis Maria is referenced in SEC filings as of June 9, 2026 in connection with CRISPR Therapeutics AG. The provided context does not include a public corporate title, role, or biography. Based on the SEC context alone, she appears to be an individual associated with CRISPR Therapeutics AG, but a definitive current position, tenure, or background is not specified in the available data.
| Role | Insider |
|---|
| Notability | 10/100 |
|---|
Board memberships
Awards & honors
- Publicly documented only as an SEC-filings-associated individual with CRISPR Therapeutics AG (as of 2026-06-09)
Frequently Asked Questions
Who is Fardis Maria?
Fardis Maria is referenced in SEC filings as of June 9, 2026 in connection with CRISPR Therapeutics AG. The provided context does not include a public corporate title, role, or biography. Based on the SEC context alone, she appears to be an individual associated with CRISPR Therapeutics AG, but a definitive current position, tenure, or background is not specified in the availab…
How many SEC Form 4 filings has Fardis Maria submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Fardis Maria's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.